HSBC Holdings
TEVA icon

HSBC Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

HSBC Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.8M Buy
961,140
+350,534
+57% +$11.3M 0.02% 653
2025
Q4 		$19.1M Sell
610,606
-868,090
-59% -$21.4M 0.01% 762
2025
Q3 		$29.9M Buy
1,478,696
+62,337
+4% +$1.09M 0.02% 601
2025
Q2 		$23.8M Buy
1,416,359
+33,187
+2% +$536K 0.01% 658
2025
Q1 		$21.3M Buy
1,383,172
+821,883
+146% +$14.7M 0.01% 687
2024
Q4 		$12.4M Buy
561,289
+30,155
+6% +$549K 0.01% 864
2024
Q3 		$9.49M Sell
531,134
-227,271
-30% -$3.98M 0.01% 934
2024
Q2 		$12.4M Sell
758,405
-732,051
-49% -$11.3M 0.01% 812
2024
Q1 		$21M Sell
1,490,456
-106,722
-7% -$1.35M 0.01% 687
2023
Q4 		$16.7M Buy
1,597,178
+1,130,969
+243% +$10.6M 0.01% 726
2023
Q3 		$4.77M Buy
466,209
+155,388
+50% +$1.45M 0.01% 1105
2023
Q2 		$2.35M Buy
310,821
+4,237
+1% +$34.4K ﹤0.01% 1380
2023
Q1 		$2.72M Buy
306,584
+116,915
+62% +$1.16M ﹤0.01% 1381
2022
Q4 		$1.73M Sell
189,669
-69,744
-27% -$609K ﹤0.01% 1746
2022
Q3 		$2.1M Sell
259,413
-156,666
-38% -$1.39M ﹤0.01% 1544
2022
Q2 		$3.15M Buy
416,079
+75,311
+22% +$656K ﹤0.01% 1374
2022
Q1 		$3.22M Sell
340,768
-49,649
-13% -$414K ﹤0.01% 1376
2021
Q4 		$3.13M Buy
390,417
+29,393
+8% +$265K ﹤0.01% 1481
2021
Q3 		$3.52M Buy
361,024
+16,761
+5% +$157K ﹤0.01% 1306
2021
Q2 		$3.43M Sell
344,263
-40,113
-10% -$425K ﹤0.01% 1240
2021
Q1 		$4.44M Buy
384,376
+37,683
+11% +$432K 0.01% 1067
2020
Q4 		$3.32M Buy
346,693
+83,524
+32% +$800K ﹤0.01% 1178
2020
Q3 		$2.38M Buy
263,169
+70,204
+36% +$743K ﹤0.01% 1217
2020
Q2 		$2.38M Sell
192,965
-416,825
-68% -$4.71M ﹤0.01% 1120
2020
Q1 		$5.53M Sell
609,790
-1,266,994
-68% -$13M 0.01% 795
2019
Q4 		$18.5M Buy
1,876,784
+202,086
+12% +$1.8M 0.03% 548
2019
Q3 		$11.5M Buy
1,674,698
+433,491
+35% +$3.32M 0.02% 781
2019
Q2 		$11.5M Sell
1,241,207
-75,803
-6% -$914K 0.02% 768
2019
Q1 		$20.6M Buy
1,317,010
+454,512
+53% +$8.02M 0.04% 503
2018
Q4 		$13.3M Buy
862,498
+158,664
+23% +$3.25M 0.02% 669
2018
Q3 		$15.2M Buy
703,834
+102,394
+17% +$2.38M 0.02% 673
2018
Q2 		$14.6M Buy
601,440
+50,901
+9% +$1.04M 0.03% 635
2018
Q1 		$9.41M Sell
550,539
-396,968
-42% -$7.75M 0.01% 851
2017
Q4 		$18M Sell
947,507
-526,583
-36% -$7.92M 0.03% 516
2017
Q3 		$25.9M Buy
1,474,090
+993,494
+207% +$22.4M 0.04% 447
2017
Q2 		$16M Sell
480,596
-125,276
-21% -$3.88M 0.03% 580
2017
Q1 		$19.4M Buy
605,872
+173,863
+40% +$5.93M 0.04% 477
2016
Q4 		$15.7M Buy
432,009
+346,249
+404% +$13.8M 0.04% 555
2016
Q3 		$3.94M Sell
85,760
-54,298
-39% -$2.83M 0.01% 987
2016
Q2 		$7.04M Buy
140,058
+61,439
+78% +$3.27M 0.02% 787
2016
Q1 		$4.21M Sell
78,619
-81,241
-51% -$4.77M 0.01% 937
2015
Q4 		$10.5M Sell
159,860
-124,936
-44% -$7.72M 0.03% 662
2015
Q3 		$16.1M Buy
284,796
+126,487
+80% +$8.2M 0.04% 460
2015
Q2 		$9.36M Buy
158,309
+79,703
+101% +$4.92M 0.02% 637
2015
Q1 		$4.9M Buy
78,606
+50,112
+176% +$2.91M 0.01% 917
2014
Q4 		$1.63M Sell
28,494
-366,913
-93% -$20.4M ﹤0.01% 1209
2014
Q3 		$21.3M Sell
395,407
-19,957
-5% -$1.06M 0.04% 418
2014
Q2 		$21.8M Buy
415,364
+84,237
+25% +$4.31M 0.05% 389
2014
Q1 		$17.5M Buy
331,127
+294,472
+803% +$13.6M 0.04% 411
2013
Q4 		$1.47M Sell
36,655
-56,927
-61% -$2.24M ﹤0.01% 1186
2013
Q3 		$3.54M Sell
93,582
-5,982
-6% -$233K 0.01% 934
2013
Q2 		$3.9M Buy
+99,564
New +$3.88M 0.01% 757

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HSBC Holdings's TEVA Position: Q1 2026 in Review

HSBC Holdings increased its Teva Pharmaceuticals (TEVA) stake by 57% in Q1 2026, buying an estimated $11.3M and bringing the position to 961,140 shares worth $28.8M. The position accounts for 0.02% of the portfolio, ranked #653.

HSBC Holdings first reported a position in TEVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $29.9M in Q3 2025. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • HSBC Holdings held 961,140 shares of Teva Pharmaceuticals worth $28.8M as of Q1 2026.
  • HSBC Holdings bought 350,534 Teva Pharmaceuticals shares in Q1 2026, an estimated $11.3M.
  • Teva Pharmaceuticals made up 0.02% of HSBC Holdings's portfolio in Q1 2026, its #653 holding.
  • HSBC Holdings first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • HSBC Holdings's Teva Pharmaceuticals position peaked at $29.9M in Q3 2025.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.